COMP <GO>
OSTX vs XBIT // RETURN ON INVESTED CAPITAL (ROIC)
OS Therapies Incorporated (NYSE) VS. XBiotech Inc. (NASDAQ) • 15-METRIC TALLY: OSTX 1
— XBIT 2
■ METRIC PARITY
LAST: $1.15 (-7.26%) • MKT CAP: $59.8M
roic
-35.00%
LAST: $1.92 (+2.13%) • MKT CAP: $58.5M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSTX VS. XBIT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OSTX | XBIT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -21.07% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | XBIT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.5 | 38.6 | -10.10 | XBIT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $59.8M | $58.5M | $1.2M | OSTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OSTX REV | XBIT REV | OSTX GROSS % | XBIT GROSS % | OSTX FCF | XBIT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $80.4M | $155.9M | — | — | -$14.2M | -$40.2M |
| FY 2024 | $19.1M | $118.9M | — | — | -$7.3M | -$32.3M |
| FY 2023 | $12.2M | $105.0M | — | — | -$3.0M | -$18.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSTX // BETA —
XBIT // BETA —